Drugs targeted at muscle cells( Type 2 diabetes is a clinical disease c...),Health

Type 2 diabetes is a clinical disease characterised by disruption to the metabolism of glucose and lipids as well as to the production of and physiological reactions to insulin. These disruptions are partly due to a reduced absorption of glucose in the cells that form the body's fat and muscle tissue. Now scientists at Karolinska Institutet have established that a type of drug targeted at receptors in the muscle cells increases the metabolism and absorption of glucose, making it a potential tool in the treatment of diabetes.

These new findings were published recently in the scientific journal Diabetes. The study has been partly financed with two EU grants from the sixth framework programme (EUGENE2 and EXGENESIS), which were recently awarded to an international network of researchers that includes the authors of the article.

The molecular mechanisms behind Type 2 diabetes are not fully known, but both hereditary and environmental factors are thought to contribute to its development. The prevalence and number of new cases of Type 2 diabetes are steadily increasing in the West, owing, it is thought, to the excessive calorie-rich diets and more sedentary nature of typical Western lifestyles.

The receptors in the muscle cells that were studied are called peroxisome proliferators-activated delta receptors (PFAAR) and they reside in the nucleus where they regulate a large number of enzymes involved in the cell's metabolism and energy production. Using human muscle cells cultivated in vitro, the researchers were able to show that drugs that bind to PFAAR increase the absorption of glucose in the muscle cells. The two experimental drugs tested in the study were GW501516 and GW0742. The trials demonstrate that the two drugs bind to PFAAR, which triggers a series of reactions within the cells. This, in turn, helps to boost glucose absorption into the cells. By specifically blocking certain processes in the cells, the scientists were also able to show t
'"/>

Contact: Sabina Bossi
sabina.bossi@admin.ki.se
46-8-524-838-95
Karolinska Institutet
18-Apr-2005

Page: 1 2
Related medicine news :

1. Drugs users are increasingly more cautious with needles
2. Drugs for Parkinsons disease may ease stroke-related disability
3. Drugs for blood pressure and seizures among treatments recommended for essential tremor
4. Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients
5. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer
6. New mechanism identified for resistance to targeted lung cancer drugs
7. New class of HIV drug attacks previously untargeted enzyme
8. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
9. Neurons targeted by dementing illness may have evolved for complex social cognition
10. Effective HIV control may depend on viral protein targeted by immune cells
11. Fresh use of targeted therapy advances treatment of early HER2-positive breast cancer